KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE71.15-0.61 (-0.85 %)
PREV CLOSE ( ) 71.76
OPEN PRICE ( ) 72.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 46
TODAY'S LOW / HIGH ( )71.15 72.00
52 WK LOW / HIGH ( )59.3 93.2
NSE71.55-0.65 (-0.9 %)
PREV CLOSE( ) 72.20
OPEN PRICE ( ) 72.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1445
TODAY'S LOW / HIGH( ) 70.85 72.90
52 WK LOW / HIGH ( )59.2 93.95
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.